CoChat

Academia Europaea Position Paper on Translational Medicine: The Cycle Model for Translating Scientific Results into Community Benefits

Open access
Hegyi, Péter, Petersen, Ole H., Holgate, Stephen, Erőss, Bálint, Garami, András, Szakács, Zsolt, Dobszai, Dalma, Balaskó, Márta, Kemény, Lajos, Peng, Shuang, Monteiro, Joao, Varró, András, Lamont, Tara, Laurence, Jeffrey, Gray, Zoe, Pickles, Andrew, FitzGerald, Garret A., Griffiths, Christopher E.M., Jassem, Jacek, Rusakov, Dmitri A., Verkhratsky, Alexei, Szentesi, Andrea · 2020 · Journal of Clinical Medicine
Cited by 238

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Introduction: Translational science has gained prominence in medicine, but there is still much work to be done before scientific results are used optimally and incorporated into everyday health practice. As the main focus is still on generating new scientific data with financial resources primarily available for that purpose, other activities that are necessary in the transition from research to community benefit are considered less needy. The European Statistical Office of the European Commission has recently reported that 1.7 million people under 75 years of age died in Europe in 2016, with around 1.2 million of those deaths being avoidable through effective primary prevention and public health intervention. Therefore, Academia Europaea, one of the five Pan-European networks that form SAPEA (Science Advice for Policy by European Academies), a key element of the European Commission’s Scientific Advice Mechanism (SAM), has launched a project to develop a model to facilitate and accelerate the utilisation of scientific knowledge for public and community benefit. Methods: During the process, leaders in the field, including prominent basic and clinical researchers, editors-in-chief of high-impact journals publishing translational research articles, translational medicine (TM) centre leaders, media representatives, academics and university leaders, developed the TM cycle, a new model that we believe could significantly advance the development of TM. Results: This model focuses equally on the acquisition of new scientific results healthcare, understandable and digestible summation of results, and their communication to all participants. We have also renewed the definition in TM, identified challenges and recommended solutions. Conclusion: The authors, including senior officers of Academia Europaea, produced this document to serve as a basis for revising thinking on TM with the end result of enabling more efficient and cost-effective healthcare.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm9051532

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 55

  1. Narin, 1976, Structure of the Biomedical Literature, J. Am. Soc. Inf. Sci., 27, 25, 10.1002/asi.4630270104 · DOI · Paper page
  2. (2020, May 18). Scimago Journal and Country Rank (SJR). Available online: https://www.scimagojr.com/.
  3. Opthof, 2011, Differences in citation frequency of clinical and basic science papers in cardiovascular research, Med. Biol. Eng. Comput., 49, 613, 10.1007/s11517-011-0783-6 · DOI
  4. Chabner, 1998, Translational research: Walking the bridge between idea and cure—Seventeenth Bruce F. Cain Memorial Award lecture, Cancer Res., 58, 4211
  5. Sung, 2003, Central challenges facing the national clinical research enterprise, JAMA, 289, 1278, 10.1001/jama.289.10.1278 · DOI · Paper page
  6. Fitzgerald, 2005, Opinion: Anticipating change in drug development: The emerging era of translational medicine and therapeutics, Nat. Rev. Drug Discov., 4, 815, 10.1038/nrd1849 · doi:10.1038/nrd1849
  7. Saijo, 2002, Translational study in cancer research, Intern. Med., 41, 770, 10.2169/internalmedicine.41.770 · doi:10.2169/internalmedicine.41.770
  8. Chan, 2005, New insights on brain stem death: From bedside to bench, Prog. Neurobiol., 77, 396, 10.1016/j.pneurobio.2005.11.004 · DOI
  9. Goldblatt, 2010, From bench to bedside: The growing use of translational research in cancer medicine, Am. J. Transl. Res., 2, 1
  10. Recke, 2014, From bedside to bench—Reverse translational medicine. Scientific lessons from revertant mosaicism in ‘knockout’ humans, Exp. Dermatol., 23, 549, 10.1111/exd.12475 · DOI
  11. Cohrs, 2015, Translational Medicine definition by the European Society for Translational Medicine, New Horiz. Transl. Med., 2, 86
  12. Surkis, 2016, Classifying publications from the clinical and translational science award program along the translational research spectrum: A machine learning approach, J. Transl. Med., 14, 235, 10.1186/s12967-016-0992-8 · DOI
  13. Puljak, 2017, Acceptance of a systematic review as a thesis: Survey of biomedical doctoral programs in Europe, Syst. Rev., 6, 253, 10.1186/s13643-017-0653-x · DOI
  14. FitzGerald, 2013, Anecdotes from ITMAT: Building capacity for translational science, Clin. Pharmacol. Ther., 94, 291, 10.1038/clpt.2013.84 · doi:10.1038/clpt.2013.84
  15. Gristwood, 2019, A focus on excellence: An interview with Iain Mattaj, former Director-General of EMBL and Director of the Human Technopole, EMBO Rep., 20, e47613, 10.15252/embr.201847613 · doi:10.15252/embr.201847613
  16. Petersen, 2019, Reproducibility-again, J. Physiol., 597, 657, 10.1113/JP277486 · DOI
  17. Boaz, 2015, Does the engagement of clinicians and organisations in research improve healthcare performance: A three-stage review, BMJ Open, 5, e009415, 10.1136/bmjopen-2015-009415 · DOI · Paper page
  18. Rochon, J., du Bois, A., and Lange, T. (2014). Mediation analysis of the relationship between institutional research activity and patient survival. BMC Med. Res. Methodol., 14. · DOI · Paper page
  19. Selby, 2011, The impact of the process of clinical research on health service outcomes, Ann. Oncol., 22, vii5, 10.1093/annonc/mdr419 · doi:10.1093/annonc/mdr419
  20. Godi, 2018, Centralized care for acute pancreatitis significantly improves outcomes, J. Gastrointest. Liver Dis., 27, 151, 10.15403/jgld.2014.1121.272.pan · DOI
  21. Ringelstein, 2013, European Stroke Organisation recommendations to establish a stroke unit and stroke center, Stroke, 44, 828, 10.1161/STROKEAHA.112.670430 · DOI · Paper page
  22. Ruben, 2019, Dosing time matters, Science, 365, 547, 10.1126/science.aax7621 · DOI · Paper page
  23. Austin, 2018, Translating translation, Nat. Rev. Drug Discov., 17, 455, 10.1038/nrd.2018.27 · DOI
  24. Waldman, 2010, Clinical and translational science: From bench-bedside to global village, Clin. Transl. Sci., 3, 254, 10.1111/j.1752-8062.2010.00227.x · DOI
  25. Brook, 2010, Medical leadership in an increasingly complex world, JAMA, 304, 465, 10.1001/jama.2010.1049 · DOI
  26. FitzGerald, 2018, The future of humans as model organisms, Science, 361, 552, 10.1126/science.aau7779 · DOI
  27. Melamud, 2020, The promise and reality of therapeutic discovery from large cohorts, J. Clin. Investig., 130, 575, 10.1172/JCI129196 · DOI
  28. 2017, The science that’s never been cited, Nature, 552, 162, 10.1038/d41586-017-08404-0 · DOI
  29. Ketcham, 2007, The impact of review articles, Lab. Investig., 87, 1174, 10.1038/labinvest.3700688 · DOI
  30. Garfield, 1994, The impact factor, Curr. Contents, 25, 3
  31. Simons, 2008, The misused impact factor, Science, 322, 165, 10.1126/science.1165316 · DOI · Paper page
  32. Petersen, O.H. (2020). FUNCTION Is Now Functional, Oxford University Press. · doi:10.1093/function/zqaa001
  33. Ioannidis, 2019, A user’s guide to inflated and manipulated impact factors, Eur. J. Clin. Investig., 49, e13151, 10.1111/eci.13151 · DOI
  34. Callaway, 2013, Preprints come to life, Nature, 503, 180, 10.1038/503180a · DOI
  35. Zadori, 2020, Insufficient implementation of the IAP/APA guidelines on aetiology in acute pancreatitis: Is there a need for implementation managers in pancreatology?, United Eur. Gastroenterol. J., 8, 246, 10.1177/2050640620918695 · doi:10.1177/2050640620918695
  36. Baron, 2017, Clinical guidelines: How can we improve adherence and implementation?, Eur. J. Anaesthesiol., 34, 329, 10.1097/EJA.0000000000000603 · DOI
  37. Nordback, 2009, The recurrence of acute alcohol-associated pancreatitis can be reduced: A randomized controlled trial, Gastroenterology, 136, 848, 10.1053/j.gastro.2008.11.044 · DOI · Paper page
  38. King, 2017, Consultative review is worth the wait, Elife, 6, e32012, 10.7554/eLife.32012 · DOI
  39. Uiters, 2016, Health literacy in Europe: The development and validation of health literacy prediction models, Eur. J. Public Health, 26, 906, 10.1093/eurpub/ckw078 · DOI
  40. Rajah, 2018, The perspective of healthcare providers and patients on health literacy: A systematic review of the quantitative and qualitative studies, Perspect. Public Health, 138, 122, 10.1177/1757913917733775 · DOI
  41. Dijkstra, 2018, Possibilities and Pitfalls of Social Media for Translational Medicine, Front. Med. (Lausanne), 5, 345, 10.3389/fmed.2018.00345 · DOI
  42. Bouwense, 2015, Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): A multicentre randomised controlled trial, Lancet, 386, 1261, 10.1016/S0140-6736(15)00274-3 · DOI · Paper page
  43. Hanna, 2018, Funding breakthrough therapies: A systematic review and recommendation, Health Policy, 122, 217, 10.1016/j.healthpol.2017.11.012 · DOI
  44. Madon, 2007, Public health. Implementation science, Science, 318, 1728, 10.1126/science.1150009 · DOI · Paper page
  45. Gilliland, 2016, Putting translational science on to a global stage, Nat. Rev. Drug Discov., 15, 217, 10.1038/nrd.2016.33 · DOI
  46. Alving, B., Dai, K., and Chan, S.H.H. (2013). Translational Medicine–What, Why and How: An International Perspective, Translational Research in Biomedicine, Karger. · doi:10.1159/isbn.978-3-318-02285-8
  47. Denne, S.C., Sajdyk, T., Sorkness, C.A., Drezner, M.K., and Shekhar, A. (2013). Utilizing Pilot Funding and Other Incentives to Stimulate Interdisciplinary Research, Translational Research in Biomedicine, Karger. · DOI
  48. Tarantal, A.F., Rainwater, J., Wun, T., and Berglund, L. (2013). The US Initiative: Clinical and Translational Science Awards–The UC Davis Perspective, Translational Research in Biomedicine, Karger. · DOI
  49. Serger, 2007, China’s Fifteen-Year Plan for Science and Technology: An Assessment, Asia Policy, 4, 64
  50. Shi, T.Z., and Dai, K. (2013). Training Translational Investigators in China, Translational Research in Biomedicine, Karger. · DOI
  51. Soderquest, 2010, Strategies for translational research in the United Kingdom, Sci. Transl. Med., 2, 53cm28, 10.1126/scitranslmed.3001129 · doi:10.1126/scitranslmed.3001129
  52. Skarke, 2010, Training translators for smart drug discovery, Sci. Transl. Med., 2, 26cm12, 10.1126/scitranslmed.3000890 · DOI
  53. Meagher, 2011, Efficient drug approval and monitoring must rely on sound regulatory science, Nat. Med., 17, 1535, 10.1038/nm1211-1535 · DOI
  54. Scheffler, R.M. (2016). Translational Health Economics. World Scientific Handbook of Global Health Economics and Public Policy, World Scientific Publishing Company. · doi:10.1142/9200-vol1
  55. Hastings, 2012, Clinical research nursing: A critical resource in the national research enterprise, Nurs. Outlook, 60, 149, 10.1016/j.outlook.2011.10.003 · DOI

Cited by

See all 238

Metadata

Authors
Hegyi, P., Petersen, O. H., Holgate, S., Erőss, B., Garami, A., Szakács, Z., Dobszai, D., Balaskó, M., Kemény, L., Peng, S., Monteiro, J., Varró, A., Lamont, T., Laurence, J., Gray, Z., Pickles, A., FitzGerald, G. A., Griffiths, C. E. M., Jassem, J., Rusakov, D. A., Verkhratsky, A., & Szentesi, A.
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2020-05-19
Volume
9
Issue
5
Pages
1532
ISSN
2077-0383 (ISSN-L)
OpenAlex
W3026284030
Cited by
238
References
8
FWCI
7.57
Type
journal article
Language
en
Open access
gold
Funders
  • Hubert Curien Initiatives Fund of Academia Europaea via its Cardiff Knowledge Hub (-)
  • Medical School of the University of Pécs (-)
  • Economic Development and Innovation Operational Programme Grant (GINOP 2.3.2-15-2016-00048)
  • NIHR Biomedical Research Centre at South London (-)
  • Maudsley NHS Foundation Trust (-)
  • NIHR Senior Investigator award (NF-SI-0617-10120)
  • NIHR Manchester Biomedical Research Centre (-)
  • National Institute of Health (U54TR001623)
  • Medical Scientific Research Foundation of Guangdong Province, China (A2019205)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.